IL2 and neoplasm: Accordingly, hypoxia, TNF-α, TGF-β, IL2-STAT5, and the mTORC1 pathways were enriched in recurrent tumor cells (Supplementary Fig. 6f), suggesting that these pathways may be critical for the OS chemotherapeutic resistance and tumor recurrence.